Navigation Links
Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351
Date:9/4/2008

CPX-351 awarded orphan designation for the treatment of Acute Myeloid

Leukemia

PRINCETON, N.J., Sept. 4 /PRNewswire/ -- Celator Pharmaceuticals today announced that the U.S. Food & Drug Administration (FDA) has granted orphan drug designation to CPX-351 (Cytarabine:Daunorubicin) Liposome Injection for the treatment of Acute Myeloid Leukemia (AML).

Celator is currently preparing to conduct two randomized Phase 2 studies with CPX-351. The first Phase 2 study, in newly diagnosed, elderly patients with AML, is expected to start enrolling patients before the end of 2008. The second study, in AML patients who have relapsed following initial treatment, is projected to start enrolling patients in the first quarter of 2009.

Interim Phase 1 data with CPX-351, where complete remissions were obtained in patients with advanced leukemia, were reported in December 2007. The company submitted additional CPX-351 preclinical and clinical data to this year's American Society of Hematology (ASH) meeting in December and will report Phase 1 results at that time.

CPX-351 is a liposomal formulation of cytarabine and daunorubicin delivered in a 5:1 molar ratio shown to be strongly synergistic in preclinical studies. CPX-351 was developed using Celator's proprietary CombiPlex(R) technology platform.

Orphan drug status is granted to treatments for diseases that affect fewer than 200,000 people in the United States and provides the benefits of market exclusivity for seven years, tax credits, and a waiver of FDA user fees.

"The decision by FDA to grant CPX-351 orphan drug designation reinforces the importance of developing novel products for the treatment of rare diseases and represents another milestone for the company," said Scott Jackson, chief executive officer of Celator Pharmaceuticals. "We are committed to developing products that will benefit patients and look forward to initiating enrollment in our CPX-
'/>"/>

SOURCE Celator Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
2. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer
3. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
4. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
5. Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
6. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
7. Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
8. Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies
9. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
10. Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000
11. Addrenex Pharmaceuticals New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Today the Council of State and ... companies, retailers, and human and animal health stakeholders ... CSTE is committed to supporting changes that slow ... preserve the efficacy of our existing antibiotics, and ... CSTE continues to serve as a key partner ...
(Date:6/2/2015)... -- Stoltenberg Consulting , a leading healthcare ... celebration of its 20-year anniversary and over 250 ... inception in 1995. "As the ... technology industry continues, we strive to combine experienced ... clients, organizational goals, understanding that today,s healthcare providers ...
(Date:6/2/2015)... FORT WORTH, Texas , June 2, 2015  ErgoNurse, ... a preeminent supplier of healthcare products in the ... serve the hospice, nursing home, long-term care and skilled nursing ... - http://photos.prnewswire.com/prnh/20150601/219779LOGO ... settings have been able to fully take advantage of the ...
Breaking Medicine Technology:Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 2Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 3ErgoNurse and Briggs Healthcare Positioned to Completely Eliminate the Unnecessary Cost of Healthcare-Related Back Injuries 2
... 2010 SRI International, an independent nonprofit research ... collaborating with PhenoMatriX (PMX), a biotechnology company, on ... as cisplatin and related analogues are used to ... as major weapons against solid tumors and other ...
... 2, 2010 Advanced Life Sciences ... ), a biopharmaceutical company engaged in the discovery, development ... of infection, oncology and respiratory diseases, announced today that ... of Advanced Life Sciences. The report highlights Restanza™ (cethromycin) ...
Cached Medicine Technology:SRI International and PhenoMatriX Collaborate to Develop Platin-Based Chemotherapies 2SRI International and PhenoMatriX Collaborate to Develop Platin-Based Chemotherapies 3SRI International and PhenoMatriX Collaborate to Develop Platin-Based Chemotherapies 4Dawson James Initiates Research Coverage of Advanced Life Sciences 2Dawson James Initiates Research Coverage of Advanced Life Sciences 3
(Date:6/2/2015)... Milton Hershey School® graduate Vincent Klomps ’10 ... of the Physician Assistant Program’s entering class of 2015 ... with a white coat, which symbolizes his entrance into ... of Vincent’s accomplishments both at MHS and postgraduation,” said ... of how a top-notch education can lead to achievement ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Erbelli’s Gourmet ... website to promote its handmade gourmet pizzas and calzones, ... though the website is new, the recipes are not—they ... 1995. The main feature of the site is the ... pictures and descriptions of all the items. You can ...
(Date:6/2/2015)... California (PRWEB) June 02, 2015 ... and sorbent systems, has announced the availability of ... ingestion of poisons by children, especially curious toddlers. ... D3475 standards and tested to CFR 1700.20 protocols. ... Kevin Cullen. , Looks Like Candy, “With the ...
(Date:6/2/2015)... 02, 2015 Acara Partners has seen a ... responsive to mobile devices, as is now required by recent ... clients, as well as several new clients in the medical ... website for them to meet Google’s new requirements,” commented Fran ... with our clients in education, non-profits, and the business world.” ...
(Date:6/2/2015)... Nashville, Tennessee (PRWEB) June 02, 2015 ... leading functional drug response profiling test to help ... from the College of American Pathologists (CAP) for ... “Receiving the CAP certification is equivalent to the ... Henry, president and chief executive officer for DiaTech. ...
Breaking Medicine News(10 mins):Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2Health News:Acara Partners Expands Website and Digital Offerings 2Health News:DiaTech Oncology Gains College of American Pathologists Accreditation for U.S. CorrectChemo Laboratory 2
... new study shows that combining a technology called ... distinguish early-stage breast cancer from non-cancerous lesions--and potentially ... ,Only 10 to 15 percent of women ... malignant tumor, leading many women to experience unnecessary ...
... and radioactive substances called radioisotopes to produce images of ... other organs//. What makes the procedure so valuable is ... without disturbing the normal bodily functions. ,Ever ... has been possible to identify any structural and functional ...
... getting affected by mouth disease and mouth cancer. The reasons ... unhealthy foods by young//. The survey points out that frequent ... to be done by the young, as early detection and ... be helpful for curing mouth cancer. ,As it ...
... gorge on burgers and other junk food, here's some ... to make it healthier//. ,Professor Jeff Pearson of ... other researchers examined the properties of a brown-coloured seaweed ... South America and parts of Norway and Scotland. ...
... the September issue of Archives of Internal Medicine, poor ... and mental conditions//. ,Besides basic reading skills, individuals ... information such as that on prescription bottles and be ... appointment slips, to be able to call themselves health ...
... One of the main challenges faced by dentists since times ... the satisfaction of their patients. The problem of missing teeth ... or simply old age. Traditionally, complete dentures have performed the ... be said that they were a compromise as far as ...
Cached Medicine News:Health News:Chest Pain Can Be Identified By New Tracer Chemical 30 Hours After Pain Relief 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: